BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29879947)

  • 1. The impact of early outcome events on the effect of tranexamic acid in post-partum haemorrhage: an exploratory subgroup analysis of the WOMAN trial.
    Brenner A; Shakur-Still H; Chaudhri R; Fawole B; Arulkumaran S; Roberts I;
    BMC Pregnancy Childbirth; 2018 Jun; 18(1):215. PubMed ID: 29879947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.
    WOMAN Trial Collaborators
    Lancet; 2017 May; 389(10084):2105-2116. PubMed ID: 28456509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial.
    Shakur H; Roberts I; Edwards P; Elbourne D; Alfirevic Z; Ronsmans C
    Trials; 2016 May; 17(1):249. PubMed ID: 27188698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial.
    Shakur H; Elbourne D; Gülmezoglu M; Alfirevic Z; Ronsmans C; Allen E; Roberts I
    Trials; 2010 Apr; 11():40. PubMed ID: 20398351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial.
    Ker K; Roberts I; Chaudhri R; Fawole B; Beaumont D; Balogun E; Prowse D; Pepple T; Javaid K; Kayani A; Arulkumaran S; Bates I; Shakur-Still H;
    Trials; 2018 Dec; 19(1):712. PubMed ID: 30594227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid for post-partum haemorrhage: What, who and when.
    Brenner A; Ker K; Shakur-Still H; Roberts I
    Best Pract Res Clin Obstet Gynaecol; 2019 Nov; 61():66-74. PubMed ID: 31128974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
    Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
    Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
    Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid for treatment of women with post-partum haemorrhage in Nigeria and Pakistan: a cost-effectiveness analysis of data from the WOMAN trial.
    Li B; Miners A; Shakur H; Roberts I;
    Lancet Glob Health; 2018 Feb; 6(2):e222-e228. PubMed ID: 29389542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial.
    Bouthors AS; Hennart B; Jeanpierre E; Baptiste AS; Saidi I; Simon E; Lannoy D; Duhamel A; Allorge D; Susen S
    Trials; 2018 Mar; 19(1):148. PubMed ID: 29490682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.
    CRASH-3 trial collaborators
    Lancet; 2019 Nov; 394(10210):1713-1723. PubMed ID: 31623894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients.
    Gayet-Ageron A; Prieto-Merino D; Ker K; Shakur H; Ageron FX; Roberts I;
    Lancet; 2018 Jan; 391(10116):125-132. PubMed ID: 29126600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
    HALT-IT Trial Collaborators
    Lancet; 2020 Jun; 395(10241):1927-1936. PubMed ID: 32563378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS]).
    Mahmood A; Roberts I; Shakur H
    Trials; 2017 Jul; 18(1):330. PubMed ID: 28716153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial.
    Brenner A; Afolabi A; Ahmad SM; Arribas M; Chaudhri R; Coats T; Cuzick J; Gilmore I; Hawkey C; Jairath V; Javaid K; Kayani A; Mutti M; Nadeem MA; Shakur-Still H; Stanworth S; Veitch A; Roberts I;
    Trials; 2019 Jul; 20(1):467. PubMed ID: 31362765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does tranexamic acid prevent postpartum haemorrhage? A systematic review of randomised controlled trials.
    Ker K; Shakur H; Roberts I
    BJOG; 2016 Oct; 123(11):1745-52. PubMed ID: 27558956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-partum haemorrhage and tranexamic acid: a global issue.
    Hibbs SP; Roberts I; Shakur-Still H; Hunt BJ
    Br J Haematol; 2018 Mar; 180(6):799-807. PubMed ID: 29318575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-fibrinolytic agents in post partum haemorrhage: a systematic review.
    Ferrer P; Roberts I; Sydenham E; Blackhall K; Shakur H
    BMC Pregnancy Childbirth; 2009 Jul; 9():29. PubMed ID: 19604358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
    ; Roberts I; Shakur H; Afolabi A; Brohi K; Coats T; Dewan Y; Gando S; Guyatt G; Hunt BJ; Morales C; Perel P; Prieto-Merino D; Woolley T
    Lancet; 2011 Mar; 377(9771):1096-101, 1101.e1-2. PubMed ID: 21439633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid in the routine treatment of postpartum hemorrhage in the United States: a cost-effectiveness analysis.
    Sudhof LS; Shainker SA; Einerson BD
    Am J Obstet Gynecol; 2019 Sep; 221(3):275.e1-275.e12. PubMed ID: 31226298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.